Impact of Chronic Liver Disease in Intensive Care Unit Acquired Pneumonia: a Prospective Study

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2013 Aug 3

PMID 23907496

Citations 11

Authors

Marta Di Pasquale

Mariano Esperatti

Ernesto Crisafulli

Miquel Ferrer

Gianluigi Li Bassi

Mariano Rinaudo

Angels Escorsell

Javier Fernandez

Antoni Mas

Francesco Blasi

Antoni Torres

Affiliations

Soon will be listed here.

Abstract

Purpose: To assess the impact of chronic liver disease (CLD) on ICU-acquired pneumonia.

Methods: This was a prospective, observational study of the characteristics, microbiology, and outcomes of 343 consecutive patients with ICU-acquired pneumonia clustered according to the presence of CLD.

Results: Sixty-seven (20%) patients had CLD (67% had liver cirrhosis, LC), MELD score 26 ± 9, 20% Child-Pugh class C). They presented higher severity scores than patients without CLD both on admission to the ICU (APACHE II, LC 19 ± 6 vs. other CLD 18 ± 6 vs. no CLD 16 ± 6; p < 0.001; SOFA, 10 ± 3 vs. 8 ± 4 vs. 7 ± 3; p < 0.001) and at onset of pneumonia (APACHE II, 19 ± 6 vs. 17 ± 6 vs. 16 ± 5; p = 0.001; SOFA, 11 ± 4 vs. 9 ± 4 vs. 7 ± 3; p < 0.001). Levels of CRP were lower in patients with LC than in the other two groups (day 1, 6.5 [2.5-11.5] vs. 13 [6-23] vs. 15.5 [8-24], p < 0.001, day 3, 6 [3-12] vs. 16 [9-21] vs. 11 [5-20], p = 0.001); all the other biomarkers were higher in LC and other CLD patients. LC patients had higher 28- and 90-day mortality (63 vs. 28%, p < 0.001; 72 vs. 38%, p < 0.001, respectively) than non-CLD patients. Presence of LC was independently associated with decreased 28- and 90-day survival (95% confidence interval [CI], 1.982-17.250; p = 0.001; 95% confidence interval [CI], 2.915-20.699, p = 0.001, respectively).

Conclusions: In critically ill patients with ICU-acquired pneumonia, CLD is associated with a more severe clinical presentation and poor clinical outcomes. Moreover, LC is independently associated with 28- and 90-day mortality. The results of this study are important for future trials focused on mortality.

Citing Articles

Factors Associated with Mortality in Nosocomial Lower Respiratory Tract Infections: An ENIRRI Analysis.

Reyes L, Torres A, Olivella-Gomez J, Ibanez-Prada E, Nseir S, Ranzani O Antibiotics (Basel). 2025; 14(2).

PMID: 40001371 PMC: 11851455. DOI: 10.3390/antibiotics14020127.

Adverse Outcomes of Patients with Non-Ventilator-Associated Hospital-Acquired Pneumonia (nvHAP)-A Single Centre Cohort Study.

Amodio E, Schreiber P, Faes Hesse M, Wolfensberger A Infect Dis Rep. 2024; 16(2):228-238.

PMID: 38525765 PMC: 10961785. DOI: 10.3390/idr16020018.

Are Cirrhotic Patients Receiving Invasive Mechanical Ventilation at Risk of Abundant Microaspiration.

Levy C, Gaudet A, Jaillette E, Reignier J, Lassailly G, Balduyck M J Clin Med. 2022; 11(20).

PMID: 36294314 PMC: 9604551. DOI: 10.3390/jcm11205994.

Liver stiffness is associated with disease severity and worse clinical scenarios in coronavirus disease 2019: A prospective transient elastography study.

Demirtas C, Keklikkiran C, Ergenc I, Erturk Sengel B, Eskidemir G, Cinel I Int J Clin Pract. 2021; 75(9):e14363.

PMID: 33993597 PMC: 8237050. DOI: 10.1111/ijcp.14363.

Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.

Lippi G, de Oliveira M, Henry B Eur J Gastroenterol Hepatol. 2020; 33(1):114-115.

PMID: 32282549 PMC: 7690326. DOI: 10.1097/MEG.0000000000001742.

References

Fagon J, Chastre J, HANCE A, Montravers P, Novara A, Gibert C . Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med. 1993; 94(3):281-8. DOI: 10.1016/0002-9343(93)90060-3. View

Garcia-Tsao G . Bacterial infections in cirrhosis. Can J Gastroenterol. 2004; 18(6):405-6. DOI: 10.1155/2004/769615. View

Kollef M . Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. Clin Infect Dis. 2010; 51 Suppl 1:S29-35. DOI: 10.1086/653037. View

Huang D, Angus D, Kellum J, Pugh N, Weissfeld L, Struck J . Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest. 2009; 136(3):823-831. PMC: 2818411. DOI: 10.1378/chest.08-1981. View

Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V . Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002; 35(1):140-8. DOI: 10.1053/jhep.2002.30082. View

Harden L, Rummel C, Luheshi G, Poole S, Gerstberger R, Roth J . Interleukin-10 modulates the synthesis of inflammatory mediators in the sensory circumventricular organs: implications for the regulation of fever and sickness behaviors. J Neuroinflammation. 2013; 10:22. PMC: 3582531. DOI: 10.1186/1742-2094-10-22. View

Deschenes M, Villeneuve J . Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol. 1999; 94(8):2193-7. DOI: 10.1111/j.1572-0241.1999.01293.x. View

Caly W, Strauss E . A prospective study of bacterial infections in patients with cirrhosis. J Hepatol. 1993; 18(3):353-8. DOI: 10.1016/s0168-8278(05)80280-6. View

Knaus W, Draper E, Wagner D, Zimmerman J . APACHE II: a severity of disease classification system. Crit Care Med. 1985; 13(10):818-29. View

10.

Luna C, Blanzaco D, Niederman M, Matarucco W, Baredes N, Desmery P . Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med. 2003; 31(3):676-82. DOI: 10.1097/01.CCM.0000055380.86458.1E. View

11.

Ioanas M, Ferrer M, Cavalcanti M, Ferrer R, Ewig S, Filella X . Causes and predictors of nonresponse to treatment of intensive care unit-acquired pneumonia. Crit Care Med. 2004; 32(4):938-45. DOI: 10.1097/01.ccm.0000114580.98396.91. View

12.

Lynch 3rd J . Hospital-acquired pneumonia: risk factors, microbiology, and treatment. Chest. 2001; 119(2 Suppl):373S-384S. DOI: 10.1378/chest.119.2_suppl.373s. View

13.

Cheruvattath R, Balan V . Infections in Patients With End-stage Liver Disease. J Clin Gastroenterol. 2007; 41(4):403-11. DOI: 10.1097/01.mcg.0000248018.08515.f9. View

14.

Arvaniti V, DAmico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M . Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology. 2010; 139(4):1246-56, 1256.e1-5. DOI: 10.1053/j.gastro.2010.06.019. View

15.

Calabro P, Willerson J, Yeh E . Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation. 2003; 108(16):1930-2. DOI: 10.1161/01.CIR.0000096055.62724.C5. View

16.

Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo L . Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med. 2010; 182(12):1533-9. DOI: 10.1164/rccm.201001-0094OC. View

17.

Ramirez P, Ferrer M, Marti V, Reyes S, Martinez R, Menendez R . Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med. 2011; 39(10):2211-7. DOI: 10.1097/CCM.0b013e3182257445. View

18.

. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

19.

Rosa H, Silverio A, Perini R, Arruda C . Bacterial infection in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol. 2000; 95(5):1290-3. DOI: 10.1111/j.1572-0241.2000.02026.x. View

20.

Wehler M, Kokoska J, Reulbach U, Hahn E, Strauss R . Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology. 2001; 34(2):255-61. DOI: 10.1053/jhep.2001.26522. View